Upgrade to SI Premium - Free Trial

Jefferies on Eli Lilly (LLY) competition: Oral Wegovy's TRx came in at ~94.7k on IMS & ~80.1k on Symphony

March 27, 2026 8:16 AM
Jefferies analyst Akash Tewari reiterated a Buy rating and $1,300.00 price target on Eli Lilly (NYSE: LLY)The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments